Phreesia, Inc. (PHR)
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$10.94-1.44%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · PHR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 507.8 | 480.6 | 419.8 | 356.3 | 280.9 | 213.2 | 148.7 | 124.8 |
| Total Revenues | 507.8 | 480.6 | 419.8 | 356.3 | 280.9 | 213.2 | 148.7 | 124.8 |
| Operating Expenses & Income | ||||||||
| R&D Expenses | 116.3 | 121.5 | 117.4 | 112.3 | 91.2 | 52.3 | 22.6 | 18.6 |
| Operating Income | 12.5 | (6.6) | (58.1) | (136.5) | (176.6) | (116.8) | (25.7) | (15.3) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | 7.0 | 2.3 | 1.9 | 1.4 | 1.2 | 1.7 | 3.0 |
| Interest & Investment Income | 1.5 | 2.2 | 2.7 | — | 2.5 | — | — | — |
| Net Interest Expenses | — | — | — | — | (1.1) | — | — | — |
| Other Non-Operating Income / Expenses | (9.8) | (2.3) | 2.3 | 1.1 | 0.9 | (1.2) | (1.6) | (6.8) |
| Asset Writedown | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | 2.8 | (8.9) | (55.8) | (135.3) | (175.7) | (118.0) | (27.2) | (22.1) |
| Income Tax Expense | (7.7) | (11.2) | 2.7 | 1.5 | 0.5 | 0.2 | 0.0 | (1.8) |
| Net Income | ||||||||
| Net Income | 10.4 | 2.3 | (58.5) | (136.9) | (176.1) | (118.2) | (27.3) | (20.3) |
| Per Share | ||||||||
| Basic EPS | 0.17 | 0.04 | (1.02) | (2.51) | (3.36) | (2.37) | (0.69) | (4.50) |
| Diluted EPS | 0.17 | 0.04 | (1.02) | (2.51) | (3.36) | (2.37) | (0.69) | (4.50) |
| Revenue per Share | 8.13 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 61.9 | 59.7 | 57.6 | 54.6 | 52.4 | 49.9 | 39.5 | 20.3 |
| Diluted Weighted Avg Shares | 62.5 | 61.5 | 57.6 | 54.6 | 52.4 | 49.9 | 39.5 | 20.3 |
| Supplemental | ||||||||
| EBITDA | — | 24.8 | (30.2) | (107.0) | (151.2) | (95.5) | (9.8) | (1.4) |
| EBIT | 12.5 | (6.6) | (58.1) | (136.5) | (176.6) | (116.8) | (25.7) | (15.3) |
| Effective Tax Rate | -278.0% | — | — | — | -0.3% | -0.2% | -0.2% | 8.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.